More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis.
作者信息
Chung Kian Fan
机构信息
Experimental Studies, National Heart & Lung Institute, Imperial College London, & Royal Brompton and Harefield NHS Trust, London, United Kingdom.
出版信息
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2656-2657. doi: 10.1016/j.jaip.2021.04.031. Epub 2021 Apr 26.
Abstract
摘要
相似文献
1
More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis.关于哮喘、慢性阻塞性肺疾病和支气管扩张症患者感染新型冠状病毒肺炎的风险及转归的更多数据。
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2656-2657. doi: 10.1016/j.jaip.2021.04.031. Epub 2021 Apr 26.
2
New-onset obstructive airway disease following COVID-19: a multicenter retrospective cohort study.新型冠状病毒病后新发阻塞性气道疾病：一项多中心回顾性队列研究。
BMC Med. 2024 Sep 4;22(1):360. doi: 10.1186/s12916-024-03589-4.
3
Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.聚焦 COVID-19 下的哮喘和慢性阻塞性肺疾病。
J Infect Dev Ctries. 2021 Oct 31;15(10):1415-1425. doi: 10.3855/jidc.14611.
4
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases.慢性呼吸系统疾病与 COVID-19 结局的关系：一项全国范围回顾性队列研究的 39420 例病例分析。
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2645-2655.e14. doi: 10.1016/j.jaip.2021.02.041. Epub 2021 Mar 6.
5
Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.哮喘与慢性阻塞性肺疾病（COPD）共病对新型冠状病毒肺炎（COVID-19）患者疾病表现及预后的不同影响。
Allergy. 2021 Feb;76(2):483-496. doi: 10.1111/all.14517. Epub 2020 Aug 11.
6
Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population.在一个大型多民族人群中，哮喘疾病状况、COPD 和 COVID-19 严重程度。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3621-3628.e2. doi: 10.1016/j.jaip.2021.07.030. Epub 2021 Aug 10.
7
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.发展中国家的阻塞性肺疾病负担和 COVID-19：一个视角。
Curr Opin Pulm Med. 2022 Mar 1;28(2):84-92. doi: 10.1097/MCP.0000000000000836.
8
Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.哮喘、COPD 和 SARS-CoV-2 感染（COVID-19）：潜在的机制见解。
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.00920-2021. Print 2021 Aug.
9
[COVID-19 and asthma control].[新型冠状病毒肺炎与哮喘控制]
Rev Mal Respir. 2021 Jan;38(1):111-113. doi: 10.1016/j.rmr.2020.11.006. Epub 2020 Nov 17.
10
Characteristics of COVID-19 at a non-COVID tertiary pulmonary care centre in Delhi, India.印度德里一家非新冠三级肺病护理中心的新冠病毒病特征
Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1568.
引用本文的文献
1
Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection.新型冠状病毒感染后支气管扩张症患者的症状及医疗资源利用情况
Front Med (Lausanne). 2024 Jan 8;10:1276763. doi: 10.3389/fmed.2023.1276763. eCollection 2023.
2
Application of protection motivation theory in epidemic prevention in patients with respiratory diseases under the COVID-19 pandemic: A cross-sectional study.保护动机理论在 COVID-19 大流行期间呼吸系统疾病患者防疫中的应用：一项横断面研究。
Clin Respir J. 2023 Oct;17(10):1058-1066. doi: 10.1111/crj.13693. Epub 2023 Sep 4.
3
Psychological distress and symptom-related burnout in asthma during the COVID-19 pandemic.新冠疫情期间哮喘患者的心理困扰及症状相关倦怠
J Behav Med. 2023 Dec;46(6):960-972. doi: 10.1007/s10865-023-00412-y. Epub 2023 May 25.
4
The impact of facemask on patients with COPD: A systematic review and meta-analysis.口罩对 COPD 患者的影响：系统评价和荟萃分析。
Front Public Health. 2022 Nov 16;10:1027521. doi: 10.3389/fpubh.2022.1027521. eCollection 2022.
Zotero 插件